cbdMD, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
YCBD NYSE American 2834 www.cbdmd.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for cbdMD, Inc.

cbdMD Enters Definitive Agreement to Acquire Twinlab Brands, Expanding Into Legacy Supplements, Sports Nutrition, Women's Beauty, Weight Loss and Longevity Wellness - Sep 2nd, 2026 5:36 am
cbdMD Inc (YCBD) (Q3 2026) Earnings Call Highlights: Strategic Pivot and Cost Cuts Aim to ... - Aug 13th, 2026 11:04 pm
cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026 - Aug 13th, 2026 2:10 pm
cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results - Aug 10th, 2026 1:07 pm
cbdMD Applauds Proposed SENATE SPENDING BILL That Would Protect Access to Full-Spectrum CBD and Other Naturally Derived Hemp Products - Aug 3rd, 2026 9:28 am
cbdMD Supports the Bipartisan Lawful Hemp Protection Act to Protect Consumers and Full-Spectrum CBD Access - Jul 24th, 2026 11:43 am
cbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina - Jul 14th, 2026 7:23 am
cbdMD's Bluebird Botanicals Announces Official Partnership With Denver Audubon to Support Bird Conservation - Jul 9th, 2026 6:25 am
cbdMD Sets a New Safety Standard for Broad Spectrum CBD With Self-Affirmed GRAS Determination - Jul 7th, 2026 6:30 am
Oasis Launches Hemp-Derived Mixer - Jul 1st, 2026 7:00 am
cbdMD Welcomes White House Call for Fair Treatment of Hemp-Derived Products - Jun 25th, 2026 12:13 pm
cbdMD Appoints Wade Brown Chief Marketing Officer - Jun 16th, 2026 8:00 am
Why cbdMD Inc (YCBD)’s Management is Optimistic After March Quarter Results - May 31st, 2026 6:15 am
cbdMD Inc (YCBD) Q2 2026 Earnings Call Highlights: Strong Sales Growth Amidst Regulatory Challenges - May 14th, 2026 11:03 pm
cbdMD Reports 19% Year-over-Year and 12% Sequential Revenue Growth; Bluebird Acquisition Integration and Medicare BEI Pathway Position Company for Continued Momentum - May 14th, 2026 2:10 pm
cbdMD, Inc. Q3 2026 Earnings Call Summary - May 14th, 2026 6:30 am
cbdMD, Inc. Q2 2026 Earnings Call Summary - May 14th, 2026 6:30 am
cbdMD, Inc. to Host Conference Call to Discuss March 31, 2026, Second Quarter Results - May 12th, 2026 1:02 pm
Candy-Coated Costs: How Unvalidated Hemp Gummies Found a Back Door Into Medicare - May 11th, 2026 10:35 am
cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare - Apr 1st, 2026 6:30 am